Ultrasound therapy uses high energy sound waves to treat different diseases. Historically, the use of ultrasonic waves in therapy began before the wide use as a diagnostic medical imaging tool. Dependend on the intensity, ultrasound therapy reach from the thermal effect used in physical therapy to the destruction of tissue with lithotripsy.

Types of ultrasound treatment:
See also Thermal Index, History of Ultrasound, Interventional Ultrasound, and B-Mode Acquisition and Targeting.

'ALOKA, the innovator in ultrasound is the longest operating ultrasound company in the world with its main headquarters located in Tokyo, Japan.
The history of ALOKA began in 1950 when the medical equipment department of Japan Radio Company became the independent company, Medical and Physical Institute Co., Ltd.
In 1960, we developed the world's first commercially available diagnostic ultrasound system.
In 1976, our company name changed to ALOKA, which, in ancient Sanskrit, means 'Ray of Hope'.
ALOKA's ultrasound systems have been sold in the United States through distributors since the early 70s. Some of our major distributors included Johnson & Johnson Ultrasound and Corometrics Medical Systems, Inc., which also provided service for the ALOKA equipment.
In 1986 the first ALOKA office was opened in the United States.
And on January 1, 1991, ALOKA America began direct sales of ultrasound units.
All US sales, distribution and service are provided through our US headquarters located in Wallingford, Connecticut . In addition, we have sales, service and clinical applications representatives strategically located throughout the country to provide exceptional service to our customers.'

In November 2010 Hitachi Medical announced the acquisition of ALOKA.

Ultrasound Systems:

'During the 60 years since our establishment, Fukuda Denshi Co., Ltd has been involved in the development and sales for Medical Equipment in the Cardiovascular field. The history of Fukuda Denshi Co., Ltd is the history of the Electrocardiograph. From the first Electrocardiograph in Japan until now, a history of our innovations is listed.'

Ultrasound Systems:

From Medison Co.,Ltd.;
'It's the dawn of a new Evolution in affordable digital color ultrasound At Medison, we have a history of innovation. We were the first to make the leap to the third dimension when we introduced our groundbreaking digital 3D ultrasound platform with Live 3D™ technology in 1998, making it possible to capture true 3D volume data in real-time. Today, we're proud to introduce the SONOACE , the world's first true 3D color ultrasound system designed to bring the power of real-time 3D imaging to women's health specialists at a breakthrough price.'

'SONOACE 8000 Live PRIME, the true 3D ultrasound system designed to bring the power of live 3D in your hands. SONOACE 8000 Live PRIME offers superior image quality thanks to our new C-Square Technology and newly applied PSAD Beamformer.'

Lantheus Medical Imaging, Inc. engages in discovering, developing, and marketing medical imaging agents. Lantheus Medical Imaging has headquarters in North Billerica, Massachusetts, and offices in Puerto Rico, Canada, and Australia. During its history, the company launched the products Cardiolite (Technetium Tc99m Sestamibi Preparation Kit), which has become the gold standard for use in myocardial perfusion imaging, and Definity (perflutren lipid microsphere) for use in suboptimal echocardiograms.
From 2001 to 2008 Lantheus was part of the Bristol-Myers Squibb Medical Imaging, Inc. group.

Ultrasound Contrast Agents: